Mahmoud (Max) Kiaei, PhD
Dr. Kiaei is the Founder, President, and CEO of RockGen Therapeutics. He has over 20 years of pre-clinical research and drug testing experience in neurodegenerative diseases.
Mohsen (Maxim) Sharifi, PharmD., PhD
Vice President, Drug Discovery Chemistry. Dr. Sharifi brings pharmaceutical and Computer-Aided Drug Discovery expertise towards the development of computational modeling to reach milestones. He plays a leading role in the design of novel analogs, molecular simulation/docking in identifying lead candidates with a safe profile.